secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001193125-26-149828
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health regains Nasdaq equity compliance after $27M in capital events
---------------------------------------------------------------------------

- Stockholders' deficit was $18.7M at Dec 31, 2025, below Nasdaq's $2.5M minimum.
- Received $16M license fee, $3M buy-back termination, $1M inventory purchase from Woodward/Future Pak.
- Also received $2M MSA condition payment, $1.2M firm order, grant revenue, and $0.2M net sales.
- Gain of $3.4M on debt extinguishment to Chicago Venture Partners helped restore equity.
- Company believes stockholders' equity exceeded $2.5M as of April 7, 2026, curing the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526149828/0001193125-26-149828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526149828/d145473d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-149828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer